معرفی
Dr. Matti Gild is a Senior Lecturer in Medicine at the Northern Clinical School, University of Sydney, and a Staff Specialist in Endocrinology at Royal North Shore Hospital. Her expertise spans thyroid cancer research, bone metabolism, and clinical endocrinology. She holds a BSc, MBBS (Honours), PhD, and FRACP qualifications.
Dr. Gild's research focuses on RET mutant thyroid cancer signaling pathways, optimizing patient outcomes through translational research and clinical practice. Her work bridges basic science investigations into thyroid cancer genetics with clinical advancements in endocrine oncology. She collaborates with leading institutions like Memorial Sloan Kettering Cancer Centre and the Kolling Institute.
Her clinical interests include quality improvement in endocrinology, particularly in thyroid disease management. She actively contributes to professional committees such as the Endocrine Society of Australia's Early Career Committee and the US Endocrine Society's Early Career Reviewer committee.
Dr. Gild has secured research grants including the 2020 Rebecca L Cooper Medical Research Foundation grant for thyroid cancer management. Her work addresses therapeutic resistance mechanisms, novel imaging techniques (e.g., DOTATATE PET/CT), and targeted therapies for RET-mutated cancers.
Her academic contributions span over 50 peer-reviewed publications, focusing on thyroid cancer biology, osteoporosis therapeutics, and clinical decision-making tools. She mentors early-career researchers and leads collaborative initiatives to improve thyroid cancer patient care through precision medicine approaches.
